Brief: China Biotech Services Holdings Sees HY Net Loss Of Not Less Than HK$33 Mln
30/07/2019 13:00
July 30 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* EXPECTED TO RECORD A NET LOSS OF NOT LESS THAN HK$33
MILLION FOR
SIX MONTHS
* EXPECTED RESULT DUE TO INCREASE IN ADMINISTRATIVE EXPENSES
Source text for Eikon: ID:nHKS8Jq7L8
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)